SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
How Should We Intervene on the Financial Toxicity of Cancer Care? One Shot, Four Perspectives
4 references·0 citing·21 second hop
How Should We Intervene on the Financial Toxicity of Cancer Care? One Shot, Four Perspectives (2017)How Should We Intervene on the Financial …Assessment of Overall Survival, Quality of Life, and Safety Benefits Associated With New Cancer Medicines (2016)Assessment of Overall Surviva…Washington State Cancer Patients Found To Be At Greater Risk For Bankruptcy Than People Without A Cancer Diagnosis (2013)Washington State Cancer Patie…The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient's Experience (2013)The Financial Toxicity of Can…Out‐of‐pocket health care expenditure burden for Medicare beneficiaries with cancer (2012)Out‐of‐pocket health care exp…Cost of Care for Elderly Cancer Patients in the United States (2008)Evaluation of Trends in the Cost of Initial Cancer Treatment (2008)Projections of the Cost of Cancer Care in the United States: 2010-2020 (2011)Evidence-informed frameworks for cost-effective cancer care and prevention in low, middle, and high-income countries (2014)“It still affects our economic situation”: long-term economic burden of breast cancer and lymphedema (2018)Financial Toxicity in Cancer Care: Implications for Clinical Care and Potential Practice Solutions (2023)Medical Bankruptcy in the United States, 2007: Results of a National Study (2009)The development of a financial toxicity patient‐reported outcome in cancer: The COST measure (2014)Financial Hardship Associated With Cancer in the United States: Findings From a Population-Based Sample of Adult Cancer Survivors (2015)A Systematic Review of Financial Toxicity Among Cancer Survivors: We Can’t Pay the Co-Pay (2016)American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care (2009)National Estimates of Out-of-Pocket Health Care Expenditure Burdens Among Nonelderly Adults With Cancer: 2001 to 2008 (2011)Risk Factors for Financial Hardship in Patients Receiving Adjuvant Chemotherapy for Colon Cancer: A Population-Based Exploratory Analysis (2012)Financial Insolvency as a Risk Factor for Early Mortality Among Patients With Cancer (2016)Measuring financial toxicity as a clinically relevant patient‐reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST) (2016)Content Analysis: An Introduction to its Methodology. (1984)Computing Krippendorff's Alpha-Reliability (2011)American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options (2015)Efficacy, Safety, and Regulatory Approval of Food and Drug Administration–Designated Breakthrough and Nonbreakthrough Cancer Medicines (2018)Clinical Trial Evidence Supporting US Food and Drug Administration Approval of Novel Cancer Therapies Between 2000 and 2016 (2020)Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications (2021)
this work references cited by second hop

References

  • 2013The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient's Experience1,160 cited
  • 2013Washington State Cancer Patients Found To Be At Greater Risk For Bankruptcy Than People Without A Cancer Diagnosis698 cited
  • 2012Out‐of‐pocket health care expenditure burden for Medicare beneficiaries with cancer183 cited
  • 2016Assessment of Overall Survival, Quality of Life, and Safety Benefits Associated With New Cancer Medicines151 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work